116 related articles for article (PubMed ID: 10329417)
1. Reversal of MRP-mediated multidrug resistance in human lung cancer cells by the antiprogestatin drug RU486.
Payen L; Delugin L; Courtois A; Trinquart Y; Guillouzo A; Fardel O
Biochem Biophys Res Commun; 1999 May; 258(3):513-8. PubMed ID: 10329417
[TBL] [Abstract][Full Text] [Related]
2. Use of the anionic dye carboxy-2',7'-dichlorofluorescein for sensitive flow cytometric detection of multidrug resistance-associated protein activity.
Laupeze B; Amiot L; Courtois A; Vernhet L; Drenou B; Fauchet R; Fardel O
Int J Oncol; 1999 Sep; 15(3):571-6. PubMed ID: 10427142
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of multidrug resistance-associated protein (MRP) activity by rifampicin in human multidrug-resistant lung tumor cells.
Courtois A; Payen L; Vernhet L; de Vries EG; Guillouzo A; Fardel O
Cancer Lett; 1999 May; 139(1):97-104. PubMed ID: 10408915
[TBL] [Abstract][Full Text] [Related]
4. The sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cells.
Payen L; Delugin L; Courtois A; Trinquart Y; Guillouzo A; Fardel O
Br J Pharmacol; 2001 Feb; 132(3):778-84. PubMed ID: 11159731
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein.
Essodaigui M; Broxterman HJ; Garnier-Suillerot A
Biochemistry; 1998 Feb; 37(8):2243-50. PubMed ID: 9485370
[TBL] [Abstract][Full Text] [Related]
6. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone.
Li DQ; Wang ZB; Bai J; Zhao J; Wang Y; Hu K; Du YH
World J Gastroenterol; 2004 Jun; 10(12):1722-5. PubMed ID: 15188493
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells.
Vernhet L; Courtois A; Allain N; Payen L; Anger JP; Guillouzo A; Fardel O
FEBS Lett; 1999 Jan; 443(3):321-5. PubMed ID: 10025956
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
[TBL] [Abstract][Full Text] [Related]
9. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.
Draper MP; Martell RL; Levy SB
Br J Cancer; 1997; 75(6):810-5. PubMed ID: 9062400
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivities of MRP1-overexpressing lung tumor cells to cytotoxic metals.
Vernhet L; Allain N; Bardiau C; Anger JP; Fardel O
Toxicology; 2000 Jan; 142(2):127-34. PubMed ID: 10685512
[TBL] [Abstract][Full Text] [Related]
11. A leukotriene receptor antagonist, ONO-1078, modulates drug sensitivity and leukotriene C4 efflux in lung cancer cells expressing multidrug resistance protein.
Nakano R; Oka M; Nakamura T; Fukuda M; Kawabata S; Terashi K; Tsukamoto K; Noguchi Y; Soda H; Kohno S
Biochem Biophys Res Commun; 1998 Oct; 251(1):307-12. PubMed ID: 9790952
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein.
Hendrikse NH; Franssen EJ; van der Graaf WT; Meijer C; Piers DA; Vaalburg W; de Vries EG
Br J Cancer; 1998; 77(3):353-8. PubMed ID: 9472628
[TBL] [Abstract][Full Text] [Related]
13. Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide.
Vernhet L; Allain N; Payen L; Anger JP; Guillouzo A; Fardel O
Biochem Pharmacol; 2001 Jun; 61(11):1387-91. PubMed ID: 11331074
[TBL] [Abstract][Full Text] [Related]
14. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.
Feller N; Kuiper CM; Lankelma J; Ruhdal JK; Scheper RJ; Pinedo HM; Broxterman HJ
Br J Cancer; 1995 Sep; 72(3):543-9. PubMed ID: 7669559
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of P-glycoprotein activity in human leukemic cells by mifepristone.
Fardel O; Courtois A; Drenou B; Lamy T; Lecureur V; le Prisé PY; Fauchet R
Anticancer Drugs; 1996 Aug; 7(6):671-7. PubMed ID: 8913436
[TBL] [Abstract][Full Text] [Related]
16. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
17. ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion.
Feller N; Broxterman HJ; Währer DC; Pinedo HM
FEBS Lett; 1995 Jul; 368(2):385-8. PubMed ID: 7628644
[TBL] [Abstract][Full Text] [Related]
18. The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance.
Gekeler V; Ise W; Sanders KH; Ulrich WR; Beck J
Biochem Biophys Res Commun; 1995 Mar; 208(1):345-52. PubMed ID: 7887949
[TBL] [Abstract][Full Text] [Related]
19. MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs.
Giaccone G; van Ark-Otte J; Rubio GJ; Gazdar AF; Broxterman HJ; Dingemans AM; Flens MJ; Scheper RJ; Pinedo HM
Int J Cancer; 1996 Jun; 66(6):760-7. PubMed ID: 8647646
[TBL] [Abstract][Full Text] [Related]
20. Modulation by acrolein and chloroacetaldehyde of multidrug resistance mediated by the multidrug resistance-associated protein (MRP).
Manzano RG; Wright KA; Twentyman PR
Clin Cancer Res; 1996 Aug; 2(8):1321-6. PubMed ID: 9816303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
